BMY vs HUBB · P/E 17, rev $24.46B vs P/E 28, rev $5.84B
Bristol-Myers Squibb Company (BMY) versus Hubbell Inc (HUBB) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Hubbell Inc (HUBB) is a electrical equipment & parts company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported HUBB revenue for 2025-12-31 was $5.84B. Net income was $887.1M. Revenue was up 3.8% from 2024-12-31 to 2025-12-31. HUBB currently screens at market cap $22.14B and trailing P/E 28.0.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. HUBB currently screens at market cap $22.14B and trailing P/E 28.0.
Not investment advice. Open the BMY and HUBB stock pages for the full models.
Not investment advice.